KCM
Kynam Capital Management Portfolio holdings
AUM
$929M
This Quarter Return
+26.37%
1 Year Return
-7.66%
3 Year Return
+163.82%
5 Year Return
–
10 Year Return
–
AUM
$899M
AUM Growth
+$899M
(+1.7%)
Cap. Flow
-$204M
Cap. Flow
% of AUM
-22.69%
Top 10 Holdings %
Top 10 Hldgs %
85.13%
Holding
26
New
1
Increased
5
Reduced
8
Closed
3
Top Buys
| 1 |
Dynavax Technologies
DVAX
|
$33.8M |
| 2 |
Cogent Biosciences
COGT
|
$17.8M |
| 3 |
Ironwood Pharmaceuticals
IRWD
|
$14.2M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$9.79M |
| 5 |
Tyra Biosciences
TYRA
|
$2.87M |
Top Sells
| 1 |
Vera Therapeutics
VERA
|
$91.6M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$42.2M |
| 3 |
MOR
MorphoSys AG American Depositary Shares
MOR
|
$41.9M |
| 4 |
Natera
NTRA
|
$36.6M |
| 5 |
Protagonist Therapeutics
PTGX
|
$24.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Natera
NTRA
$23.1B
| $183M | 19.14% | 2,000,000 -400,000 | -17% | -$36.6M |
|
2
Syndax Pharmaceuticals
SNDX
$1.41B
| $135M | 14.1% | 5,660,000 | – | – |
|
3
Celldex Therapeutics
CLDX
$1.47B
| $122M | 12.74% | 2,900,000 -105,904 | -4% | -$4.44M |
|
|
4
Vera Therapeutics
VERA
$1.38B
| $65.8M | 6.89% | 1,526,787 -2,123,552 | -58% | -$91.6M |
|
|
5
Cogent Biosciences
COGT
$1.69B
| $57.1M | 5.98% | 8,500,000 +2,645,234 | +45% | +$17.8M |
|
|
6
Dynavax Technologies
DVAX
$1.19B
| $52.6M | 5.51% | 4,239,780 +2,725,397 | +180% | +$33.8M |
|
7
Vaxcyte
PCVX
$4B
| $50.9M | 5.33% | 745,000 -257,407 | -26% | -$17.6M |
|
8
Liquidia Corp
LQDA
$2.38B
| $33.2M | 3.47% | 2,248,324 -450,000 | -17% | -$6.64M |
|
|
9
BioCryst Pharmaceuticals
BCRX
$1.74B
| $33.2M | 3.47% | 6,527,491 +1,927,491 | +42% | +$9.79M |
|
|
10
Protagonist Therapeutics
PTGX
$3.67B
| $33.1M | 3.46% | 1,144,242 -860,633 | -43% | -$24.9M |
|
|
TSVT
11
DELISTED
2seventy bio
TSVT
| $31.9M | 3.33% | 5,953,825 | – | – |
|
12
Wave Life Sciences
WVE
$1.53B
| $24.3M | 2.54% | 3,932,082 | – | – |
|
13
Travere Therapeutics
TVTX
$1.56B
| $15.4M | 1.61% | 2,000,000 | – | – |
|
|
14
Ironwood Pharmaceuticals
IRWD
$214M
| $14.2M | 1.48% | +1,625,000 | New | +$14.2M |
|
15
Sutro Biopharma
STRO
$72.7M
| $11.3M | 1.18% | 2,001,727 | – | – |
|
|
AMRN
16
Amarin Corp
AMRN
$311M
| $10.7M | 1.12% | 12,022,957 | – | – |
|
|
17
Tyra Biosciences
TYRA
$675M
| $8.45M | 0.88% | 515,190 +175,000 | +51% | +$2.87M |
|
|
BNR
18
Burning Rock Biotech
BNR
$93.6M
| $7.02M | 0.73% | 9,640,914 +946,488 | +11% | +$689K |
|
19
Caribou Biosciences
CRBU
$174M
| $5.49M | 0.57% | 1,068,527 | – | – |
|
|
SLRN
20
DELISTED
ACELYRIN
SLRN
| $2.68M | 0.28% | 396,379 -803,621 | -67% | -$5.42M |
|
21
Viridian Therapeutics
VRDN
$1.5B
| $2.34M | 0.25% | 133,877 -474,038 | -78% | -$8.3M |
|
|
CNTA
22
Centessa Pharmaceuticals
CNTA
$2.25B
| – | – | -442,704 | Closed | -$3.52M |
|
23
Corcept Therapeutics
CORT
$7.35B
| – | – | 0 | – | – |
|
24
Vertex Pharmaceuticals
VRTX
$100B
| – | – | 0 | – | – |
|
|
MOR
25
DELISTED
MorphoSys AG American Depositary Shares
MOR
| – | – | -4,234,685 | Closed | -$41.9M |
|